Evidence map›Paper›PMID 32399643›Full record

ArticleHealth & justice2020

Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study.

Anne Bukten, Ingunn Olea Lund, Stuart A Kinner, Eline Borger Rognli, Ingrid Amalia Havnes, Ashley Elizabeth Muller, Marianne Riksheim Stavseth

Abstract read
In one paragraph

Article in Health & justice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anne BuktenNorwegian Centre for Addiction Research, University of Oslo, Kirkveien 166, 0407, Oslo, Norway. anne.bukten@medisin.uio.no.
Ingunn Olea LundNorwegian Institute of Public Health, Oslo, Norway.
Stuart A KinnerJustice Health Unit, Centre for Health Equity, Melbourne School of Population and Public Health, University of Melbourne, Melbourne, Australia.
Eline Borger RognliSection for Clinical Addiction Research, Oslo University Hospital, Oslo, Norway.
Ingrid Amalia HavnesNational Advisory Unit on SUD treatment, Oslo University Hospital, Oslo, Norway.
Ashley Elizabeth MullerNorwegian Institute of Public Health, Oslo, Norway.
Marianne Riksheim StavsethNorwegian Centre for Addiction Research, University of Oslo, Kirkveien 166, 0407, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRemarkably little is known about drug use during imprisonment, including whether it represents a continuation of pre-incarceration drug use, or whether prison is also a setting for drug use initiation. This paper aims to describe drug use among people in prison in Norway and investigate risk factors associated with in-prison drug use.

methodsWe used data from the Norwegian Offender Mental Health and Addiction (NorMA) Study, a cross-sectional survey of 1499 individuals in Norwegian prisons. Respondents reported on drug use (narcotics and non-prescribed medications) both before and during imprisonment. We used multivariate logistic regression to investigate the associations between drug use in prison and demographics, previous drug use, mental health, and criminal activity.

resultsSixty-five percent of respondents reported lifetime drug use, and about 50% reported daily use of drugs during the 6 months before incarceration. Thirty-five percent reported ever using drugs in prison, but initiation of drug used during incarceration was uncommon. In a multivariate model, factors independently associated with drug use in prison included lifetime number of drugs used (adjusted odds ratio [aOR] = 1.17; 95% confidence interval [CI] 1.12-1.23; p <  0.001), daily drug use in the 6 months before imprisonment (aOR = 7.12; 95%CI 3.99-12.70; p <  0.001), and being intoxicated while committing the crime related to current imprisonment (aOR = 2.13; 95%CI 1.13-4.03; p = 0.020).

conclusionsIn-prison drug use is independently associated with high-risk drug use before imprisonment. To reduce drug use in prison, correctional services must systematically screen for pre-prison drug use and offer effective drug treatment for those in need.

Indexed as

Drug useHarm reductionPrisonersSubstance use disordersTreatment

Identifiers

PMID32399643
PMCPMC7218530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.